基本信息
views: 324

Bio
张爱华,博士,研究员(PI),博士生导师。主要从事代谢性疾病的系 统生物学及药物作用机制研究。 主持国际科技创新合作项目、 国家自然科学基金面上项目。 现为欧洲自然科学院远东分院院长,欧洲自然科学院院士,英国皇家化学会会士,英国皇家学会工艺院会士,国际先进材料协会会士,国际科学组织协会会士、欧洲科学学会会士、美国科学荣誉学会终身成员。在STTT等杂志发表300余篇学术论文,被引用12568次,h指数63;获发明专利及软件授权40余件。曾获欧洲荣誉科学家和荣誉发明家、德国洪堡奖章、莱布尼茨奖章、欧洲荣誉勋章、Mesmer名誉教授、国际Vebleo科学家奖、中国药理学会和法国施维雅药理学家奖、全球前2%顶尖科学家、爱思唯尔中国高被引学者(药学)等荣誉奖励。
Research Interests
Papers共 436 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Shi Qiu, Zhibo Wang, Sifan Guo, Dandan Xie, Ying Cai, Xian Wang, Chunsheng Lin,Songqi Tang,Yiqiang Xie,Aihua Zhang
Cell insightno. 3 (2025): 100252-100252
Jinxuan Chai,Yan Wang,Sifan Guo, Zhibo Wang,Hongwei Chen,Xian Wang, Dandan Xie, Ying Cai,Shiwei Wang, Zhencai Hu,Aihua Zhang, Shi Qiu
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2025)
Journal of Functional Foods (2025): 106654
Ying Cai, Sifan Guo, Chunsheng Lin,Yan Wang,Chao Wang,Zhibo Wang, Dandan Xie, Yu Guan,Shi Qiu,Hui Dong,Aihua Zhang
Current pharmaceutical design (2025)
LIFE SCIENCES (2025)
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024): 117207-117207
Zhibo Wang,Sifan Guo,Ying Cai,Qiang Yang, Yan Wang,Xiaodan Yu,Wanying Sun,Shi Qiu, Xiancai Li,Yu Guo,Yiqiang Xie,Aihua Zhang,Shaojiang Zheng
BIOORGANIC CHEMISTRY (2024)
PHARMACEUTICALSno. 11 (2024)
Chunsheng Lin, Qianqian Tian,Sifan Guo,Dandan Xie,Ying Cai,Zhibo Wang,Hang Chu,Shi Qiu,Songqi Tang,Aihua Zhang
Moleculesno. 10 (2024): 2198-2198
Frontiers in cellular and infection microbiology (2024): 1463316-1463316
Load More
Author Statistics
#Papers: 437
#Citation: 16875
H-Index: 70
G-Index: 112
Sociability: 6
Diversity: 3
Activity: 33
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn